These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19083191)

  • 1. Association of the co-stimulator OX40L with systemic lupus erythematosus.
    Manku H; Graham DS; Vyse TJ
    J Mol Med (Berl); 2009 Mar; 87(3):229-34. PubMed ID: 19083191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
    Jacquemin C; Schmitt N; Contin-Bordes C; Liu Y; Narayanan P; Seneschal J; Maurouard T; Dougall D; Davizon ES; Dumortier H; Douchet I; Raffray L; Richez C; Lazaro E; Duffau P; Truchetet ME; Khoryati L; Mercié P; Couzi L; Merville P; Schaeverbeke T; Viallard JF; Pellegrin JL; Moreau JF; Muller S; Zurawski S; Coffman RL; Pascual V; Ueno H; Blanco P
    Immunity; 2015 Jun; 42(6):1159-70. PubMed ID: 26070486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
    Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OX40, OX40L and Autoimmunity: a Comprehensive Review.
    Webb GJ; Hirschfield GM; Lane PJ
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.
    Farres MN; Al-Zifzaf DS; Aly AA; Abd Raboh NM
    Ann Saudi Med; 2011; 31(1):29-34. PubMed ID: 21245596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
    Ishii N; Takahashi T; Soroosh P; Sugamura K
    Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus.
    Cunninghame Graham DS; Graham RR; Manku H; Wong AK; Whittaker JC; Gaffney PM; Moser KL; Rioux JD; Altshuler D; Behrens TW; Vyse TJ
    Nat Genet; 2008 Jan; 40(1):83-9. PubMed ID: 18059267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
    J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of CD4(+) T cell response and survival via coexpressed OX40/OX40L in Graves' disease.
    Wang Q; Shi BM; Xie F; Fu ZY; Chen YJ; An JN; Ma Y; Liu CP; Zhang XK; Zhang XG
    Mol Cell Endocrinol; 2016 Jul; 430():115-24. PubMed ID: 27107937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OX40 (CD134) and OX40L.
    Gough MJ; Weinberg AD
    Adv Exp Med Biol; 2009; 647():94-107. PubMed ID: 19760068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
    Redmond WL; Weinberg AD
    Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction.
    Song Y; Margolles-Clark E; Bayer A; Buchwald P
    Br J Pharmacol; 2014 Nov; 171(21):4955-69. PubMed ID: 24930776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
    Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis.
    Cortini A; Ellinghaus U; Malik TH; Cunninghame Graham DS; Botto M; Vyse TJ
    Ann Rheum Dis; 2017 Dec; 76(12):2095-2103. PubMed ID: 28818832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.
    Mak A; Schwarz H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OX40L/OX40 Signal Promotes IL-9 Production by Mucosal MAIT Cells During
    Ming S; Zhang M; Liang Z; Li C; He J; Chen P; Zhang S; Niu X; Deng S; Geng L; Zhang G; Gong S; Wu Y
    Front Immunol; 2021; 12():626017. PubMed ID: 33777009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21.
    Kweon S; Phan MT; Chun S; Yu H; Kim J; Kim S; Lee J; Ali AK; Lee SH; Kim SK; Doh J; Cho D
    Front Immunol; 2019; 10():879. PubMed ID: 31105701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.